Skip to main content
OpenTrials
Completed

NCT Number: NCT04809831

The Use of Biorepair Peribioma Toothpaste and Mousse for Home Oral Care in Patients Undergoing Periodontal Therapy

This is a split-mouth randomized clinical trial in which a new domiciliary oral care protocol with Biorepair Peribioma Toothpaste and Mousse is evaluated in periodontal patients.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Periodontal Diseases Mouth Diseases Stomatognathic Diseases

Age range

18 year–70 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Unit of Dental Hygiene - Section of Dentistry - Department of Clinical, Surgical, Diagnostic and Paediatrics - University of Pavia

Pavia, Lombardy, 27100, Italy

About this study

This is a split-mouth randomized clinical trial that aims to suggest an innovative protocol for domiciliary oral care of periodontal patients. In details, home use of Biorepair Peribioma Toothpaste and Mousse is proposed as a support of professional hygiene sessions.

Patients that respond to the eligibility criteria and that sign the informed consent are recruited for periodontal therapy.The first professional hygiene session is performed at the baseline (T0); the following ones will be performed after 3 (T1) and 6 months (T2) from the baseline. In each session, periodontal indices of inflammation are detected; then, subgingival removal of plaque and tartar is performed, followed by glycine air-flow application in periodontal pockets. A microbiological test is perfomed in order to detect red and orange complex bacteria. At this time, patients are randomly allocated into two groups:

  • Trial Group: domiciliary oral hygiene with Biorepair Peribioma Toothpaste and Mousse twice a day until T2 session.
  • Control Group: home oral hygiene with Curasept Toothpaste (0,2% Chlorhexidine) twice a day until T2 session.

At the end of T1 and T2 professional session, a satisfaction survey about Peribioma Toothpaste and Mousse will ben given to the patients.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Presence of periodontal disease according to the recent 2017 classification (2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions): severity grade II-III and complexity grade I-II.
  • Presence of bilateral periodontal probes, for at least one tooth per side up to 20 elements with pathologic probes).
  • Patients' good compliance

Exclusion criteria

  • Patients with cardiac pacemaker
  • Patients suffering from neurological disorders
  • Patients suffering from psychological disorders
  • Pregnant women

Treatment and study plan

Domiciliary oral care with Biorepair Peribioma Toothpaste + Mousse

Other

Patients will use Biorepair Peribioma Toothpaste and Mousse for domiciliary oral hygiene twice a day until T2 session.

Domiciliary oral care with Curasept Toothpaste (chlorhexidine 0,2%)

Other

Patients will use Curasept Toothpaste (chlorhexidine 0,2%) for domiciliary oral hygiene twice a day until T2 session.

Primary outcomes

  1. Change in BOP - Bleeding on Probing (percentage)

    Time frame: 3 and 6 months.

    Site-specific assessment of the presence or absence of gum bleeding after the insertion of the periodontal probe for the detection of PPD, detected on 6 sites.

    Percentage of sites with bleeding on probing determines the BOP%.

  2. Change in BS - Bleeding Score

    Time frame: 3 and 6 months.

    Scoring criteria:

    • 0 = no bleeding;
    • 1 = punctiform bleeding in the site of probing;
    • 2 = slightly extended bleeding in the site of probing;
    • 3 = bleeding in more than a half of gingival margin;
    • 4 = gingival border fully covered by blood.

  3. Change in SBI - Sulculus Bleeding Index (Muhulemann and Son, 1781)

    Time frame: 3 and 6 months.

    Scoring criteria:

    • 0 = healthy looking papillary and marginal gingiva, no bleeding on probing;
    • 1 = healthy looking gingiva, with bleeding on probing;
    • 2 = bleeding on probing, change in color, no edema;
    • 3 = bleeding on probing, change in color, slight edema;
    • 4 = bleeding on probing, change in color, obvious edema;
    • 5 = spontaneous bleeding, change in color, marked edema.

  4. Change in GI - Gingival Index (Loe and Silness, 1963)

    Time frame: 3 and 6 months.

    Scoring criteria:

    • 0 = normal gingiva.
    • 1 = mild inflammation, edema and swelling; no bleeding.
    • 2 = moderate inflammation with edema, swelling and bleeding on probing.
    • 3 = severe inflammation with marked edema, redness tissues, ulceration and spontaneous bleeding.

  5. Change in PPD - Probing Pocket Depth

    Time frame: 3 and 6 months.

    Evaluation (in mm) of the depth of the gingival sulcus, through a millimeter periodontal probe; it is detected from the gingival margin to the bottom of the gingival sulcus or periodontal pocket, evaluated at 6 sites.

  6. Change in CAL - Clinical Attachment Loss

    Time frame: 3 and 6 months.

    Measurement (in mm) of the position of the gingival margin in relation to the cemento-enamel junction (CEJ).

  7. Change in Percentage of pathological sites

    Time frame: 3 and 6 months.

    Evaluation of the presence of pathological probes expressed as a percentage.

  8. Change in R - Gingival recession

    Time frame: 3 and 6 months.

    Distance (in mm) between the gingival margin and the amelo-cemental junction.

  9. Change in PI - Plaque Index (Silness and Löe, 1964)

    Time frame: 3 and 6 months.

    Scoring criteria:

    • 0 = no plaque;
    • 1 = thin plaque layer at the gingival margin, only detectable by scraping with a probe;
    • 2 = moderate layer of plaque along the gingival margin; interdental spaces free, but plaque is visible to the naked eye;
    • 3 = abundant plaque along the gingival margin; interdental spaces filled with plaque.

  10. Change in Evaluation of the total height of the adherent gingiva

    Time frame: 3 and 6 months.

    Evaluation (in mm) of the total height of adherent gingiva.

  11. Change in API - Approximal Plaque Index (Lange, 1986)

    Time frame: 3 and 6 months.

    Following application of disclosing, a simple yes/no decision is made concerning whether the interproximal surfaces are covered by plaque (+) or not (-). The proportion of plaque-covered interproximal spaces is expressed as a percentage. Usually, in a given quadrant the interproximal spaces are scored from only one aspect (i.e. from the facial - Q2 and Q4 - or from the oral aspect - Q1 and Q3).

Sponsors and collaborators

Lead sponsor

University of Pavia

Other

Registry information

Official study title

A Comparison Between Biorepair Peribioma Toothpaste and Mousse Versus Chlorhexidine 0,2% Toothpaste (Curasept Trattamento Rigenerante) for Domiciliary Oral Care in Periodontal Patients.

Important dates

Study start
2021
Primary completion
2021
Study completion
2021
First posted
Mar 22, 2021
Registry last updated
Jan 13, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.